Based on 4 reference(s) in Google Scholar 8 10 4

Axon 2671

CAS [846557-71-9]

MF C29H25N3O4S
MW 511.59

  • Purity: 99%
  • Soluble in DMSO



ML385 is an inhibitor of nuclear factor erythroid 2-related factor 2 (NRF2) (IC50 value 1.9 μM), blocks NRF2 transcriptional activity, and enhances the efficacy of carboplatin and other chemotherapeutic drugs in lung cancer cells (NSCLC). Specifically, ML385 binds to Neh1, the Cap ‘N’ Collar Basic Leucine Zipper (CNC-bZIP) domain of NRF2, and interferes with the binding of the V-Maf Avian Musculoaponeurotic Fibrosarcoma Oncogene Homologue G (MAFG)-NRF2 protein complex to regulatory DNA binding sequences. ML385 shows specificity and selectivity for NSCLC cells with KEAP1 mutation.

KEYWORDS: ML385 | supplier | NRF2 inhibitor | ML-385 | ML 385 | CAS [846557-71-9] | DNA-RNA | NRF | Keap | Inhibitor | Transcription Factors | NSCLC | KEAP1 | NRF2 | CNC-bZIP | MAFG | non-small cell lung cancer

Size Unit Price Stock
10 mg €120.00 In Stock
50 mg €430.00 In Stock
Need more? Bulk Inquiry

The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.

Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!

Please wait...